Oral Drug Delivery Resources

31. Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing 6/2/2026

    In this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk. 

32. Enabling Long Lasting Clinical Outcomes In Coronary Stenting 9/12/2022

    Polyester amides (PEAs) bring several desired and differentiating properties to drug-eluting stent (DES) applications for treating coronary artery disease (CAD).

33. Platform Reduces Product Development Time And Cost By 30% 3/4/2022

    Using innovative capsule-filling equipment and processing technology, and mini-tablet and drug-layered beadlet manufacturing, you can have an adaptable, easily modified formulation.

34. Driving Sustainability In Spray Drying Through Enabling Technologies

    By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.

35. Solving For The Future Of Drug Delivery 7/16/2025

    Next-gen therapeutics require equally advanced delivery systems—localized, personalized, and precise—to ensure efficacy, safety, and scalability. Delivery is now a central driver of innovation.

36. Crystallization Process Development: Peptide Crystallization 1/24/2022

    Whether performed during formation of an API or as a means to purify intermediates, achieving control of nucleation and crystal growth is critical to designing a successful peptide crystallization process.

37. Innovative ASD Technology Improves Abandoned Cancer Medication 3/1/2024

    Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.

38. Integrated Strategies for Achieving Regulatory Milestones Faster 10/12/2023

    Learn how an innovative formulation platform reduced development timelines and allowed a sponsor to find the optimal nafamostat formulation without adding unnecessary delays.

39. Factors To Consider When Selecting A CDMO For Complex Injectables Development And Manufacture 3/1/2022

    The right CDMO partner will have specialized technologies for complex injectable development along with the equipment, facilities and operations to adopt GMP practices with a "laboratory setting."

40. Combining Patient Centricity And Commercial Viability In Pediatric Product Development 8/15/2024

    Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.